Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Inhaled Tocilizumab with Intravenous Tocilizumab in hospitalized patients with COVID-19
IRCT20151227025726N27Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of tocilizumab in coronavirus pneumonia (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
tocilizumab
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20151227025726N27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151227025726N27.